News
A focused update to AAD’s adult AD guidelines recommends tapinarof, roflumilast, lebrikizumab, and nemolizumab based on ...
A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...
Atopic dermatitis can flare up any day of the year, causing scaly patches of extremely dry, itchy, inflamed skin. But for many people living with atopic dermatitis, commonly known as eczema, the ...
New perspective proposes that skin microbiota disruption and bathing habits may play a primary role in atopic dermatitis, ...
The FDA has approved these four biologics to treat atopic dermatitis: dupilumab, lebrikizumab, nemolizumab, and tralokinumab. They are all types of biologics called monoclonal antibodies.
And atopic dermatitis is a specific form of and the most common type of eczema," dermatologist Naana Boakye, MD, says. It's a ...
Atopic dermatitis (eczema) is a long-lasting skin condition that can make areas of your skin extremely itchy. It also causes rashes that make your skin dry, inflamed, bumpy, scaly, or crusty.
Atopic dermatitis (AD) is a chronically relapsing eczematous disease, more common in infants and children than in adults and very rare after midlife. The diagnosis of AD is not always easy in ...
THE constitutional character of atopic dermatitis is generally recognized.1 The frequent association of this dermatitis with hay fever, asthma and urticaria and the demonstration of specific antibo ...
Atopic dermatitis is a chronic skin condition that causes dry, itchy red patches to appear on different parts of the body, including the elbows, knees and neck. When atopic dermatitis is more ...
Atopic dermatitis can appear differently on different people. Someone with darker skin might have brown, purple or gray rashes, while the rashes might look pink or red on lighter skin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results